VTYX has been granted a new patent
Dec 25, 2024, 11:41 PM
1.32%
What does VTYX do
Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company, develops small molecule therapeutics for autoimmune diseases with a pipeline including VTX002, VTX958, VTX2735, and VTX3232. The company went public on October 21, 2021, and employs 74 people.
VTYX filed a patent for "preparation of an s1p receptor modulator" on Fri, January 13, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
